Reneuron Share Discussion Threads

[verger] 10/12/2015 08:57

Norbus, you have to put yourself about quite a bit if you are looking for the the 'right one' for you but it does also depend how good you are at dancing! Keep going RENE!

[norbus] 10/12/2015 03:13

That's what they are trying to cure:-) but they are dancing at too many weddings which is the RF point. miKehUNT breaths a sign of relief for taking £70m to see the company through a number of important clinical milestones

[bigspuds] 09/12/2015 22:55

Yep. It's a no brainer

[ftangftang] 09/12/2015 22:40

Shares in stem cell specialist ReNeuron (RENE) fell sharply this summer as sentiment towards biotech stocks plummeted amid pricing scandals and doubts over the sustainability of sky-high valuations. But chief financial officer Michael Hunt says "nothing has changed" as the company pursues its varied clinical programme. This includes a high-profile study in the US trialling a new progenitor cell therapy for retinitis pigmentosa, a genetic condition which causes retinal degeneration and eventual blindness.

Mr Hunt nonetheless claims the group "got its timing right" when it tapped shareholders for a further £70m in July to help fund the ongoing clinical trials. That cash should see the company through a number of important clinical milestones, including the release of second-phase data for a stem cell therapy drug for motor disability as a result of stroke. That data should hit the market during the first half of the 2016 calendar year, as should data from an initial trial for another stem cell therapy designed to treat critical limb ischaemia (a severe obstruction of the arteries that reduces blood flow to the hands, feet and legs).

Analysts at Cenkos expect losses of £15.6m for the year ending March 2016, giving losses per share of 0.6p, compared with losses of £8.9m and 0.5p per share in FY2015.

.IC VIEW:
At 2.75p, the shares have fallen by almost three-fifths in just six months. While this highlights the risks of investing in loss-making companies, we are minded to remain bullish on this successful former IC tip given ReNeuron's strong balance sheet and promising drug pipeline. Buy.
Last IC view: Buy, 5.5p, 10 July 2015



cheers
ft ft

[rocket fuel] 09/12/2015 12:22

nothing falls in an absolute straight line, not even rene. enjoy the dead cat bounce while it lasts before the plunge to sub 2p.

[tradeyodha] 09/12/2015 12:17

Yep. 4p is also possible today imo

[small crow] 09/12/2015 12:13

About time.

[hutch_pod] 08/12/2015 18:27

Lol. Some decent buying.

[yachtmaster2] 08/12/2015 18:15

Well there's the bounce ! Back to 6.75 lol

[hutch_pod] 08/12/2015 16:03

Verger, also "a UK multi-site Phase II clinical trial (PISCES II) is ongoing to examine the efficacy of CTX in patients with motor disability as a result of ischaemic stroke. Sufficient suitable patients have been identified to complete the first cohort in the study, with data expected in the first half of 2016." This is probably the key news soonish.

[rocket fuel] 08/12/2015 15:24

Verger, they were all reported late but if you look at the actual trade times and if we suppose those were todays trades, when you cross reference the actual times they are mostly all closer to the sell side of the book, but anyway the eternal declinig intraday chart should give you an idea that endless amounts of worthless rene stock is flooding the market.

[verger] 08/12/2015 13:41

Rocket fuel what is your view on all the Late Trades?

[rocket fuel] 08/12/2015 13:06

Yodha i think it is you that needs to do your own research and plenty of it. i would go back to day 1 if i were you, and that is day 1 of rene mark 1 when they first came to market and raised truckloads of cash and then kept raising more cash ( they even fleeced HerMaj the Queen at £2 a pop) they soon went to the wall before relaunching rene mark 2 and ipo'd again and have raised c£170m since and are still nowhere near and not even half way through the trials and collossal cash burn stage. it's not called the 'death valley' for nothing.

[verger] 08/12/2015 13:03

All the huge trades are Late trades. Does that mean they happened earlier today? If they happened overnight they should be 'O' trades. Does this mean that all the big trades today are above the asking price?

[verger] 08/12/2015 12:56

I was referring to phase II/III trials beginning in H2 2016: "We also expect to report data from our ongoing clinical trials in critical limb ischaemia and disability as a result of stroke during 2016, representing further significant milestones in the clinical development of our CTX cell therapy candidates."

[tradeyodha] 08/12/2015 12:51

Just bought this as planned. Please dyor

[rocket fuel] 08/12/2015 12:41

what sort of share price enhancing news are you expecting next year? their leading product will not be applying for FDA approval for at least another 5 - 7yrs. and their scatter gun approach at just about trying to cure everything else at the same time (eye and lower limb as well as possible cancer technology) will just burn the much needed 001 stroke treatment cash at an alarming rate. these guys will be looking for another £100m odd cash to burn in 24 months and they will not be milking the AIM dairy next time round as they have already fleeced the mug punters out of c£170m since ipo. it will be private funding next time around as rene will then be a private delisted company after AIM suspension due to financial clarification!

[verger] 08/12/2015 12:04

Whatever your apprehensions, RENE has enough funds for at least 2016 during which time we should receive share price enhancing news. If not, then fair enough - we're sunk. But 2.5p looks very tempting.

[norbus] 07/12/2015 23:43

Unlikely that this deliberate degassing of the stock from 6 bid to 2.5 bid will be reversed on any known form. Reneuron exhibited a sclerosis of ethics that is now looking terminal. Yodha wants to reverse the sheer drop so he can lay shorts for his benefit.

[rocket fuel] 07/12/2015 18:06

with an estimated cash burn of close to £45m over the next couple of years this one is heading in one direction only.... down to a trading range between 1p - 2p before delisting and going into private hands without a penny returned to shareholders. merry crimbo from the BoD at rene and thanks for the fat bonus!

[tradeyodha] 07/12/2015 16:03

my view:



please dyor

[dickbush] 07/12/2015 11:57

NAV circa 2.3p. That probably falls to circa 1.8/1.85p by the end of 2016, by which time we should have significant news-one way or the other-on the first two product lines and, perhaps, more information on the cooperation with Benitec.

[bigspuds] 07/12/2015 10:58

So the share price is down. For no good reason it appears. You can speculate till the cows come home or you can gird your loins and "git some". I Know what I'm doing lol. Fortune favours the brave :)

[norbus] 07/12/2015 10:17

why then Is the share price staircasing down? operating steadily; all down to efficacy now with indications 6 months away; nail biting time: good results being set up for a steal, or lousy so so, drifting as the knowing ones gradually abandon

[bigspuds] 07/12/2015 09:15

Well funded, minimum cash burn, results on horizon, throw in USA and you have the perfect storm brewing for a minting machine lol